Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s rejection ...

The latest health briefs reveal Novo Nordisk's promising obesity treatment and a $7.4 billion Purdue Pharma settlement over ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

The deal represents an increase over a previous settlement rejected by the Supreme Court because it protected members of the ...

The Sackler family and Purdue Pharma, maker of OxyContin, have increased their settlement offer to $7.4 billion amid ongoing ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve ...